FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764843001: Powder for conventional release solution for infusion (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3655272013 Powder for conventional release solution for infusion (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3655273015 Powder for conventional release solution for infusion en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3655274014 Powder for solution for infusion en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for conventional release solution for infusion (dose form) Is a Parenteral dose form (dose form) false Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Has dose form administration method (attribute) A method of administration of a liquid dose form usually slowly and over a prolonged period of time and typically in larger volumes by introducing it into the circulatory system or into a body cavity. true Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Has dose form transformation (attribute) A dose form transformation that occurs when a solid dose form is mixed with a suitable liquid to create a solution. This may occur as part of the dispensing act or immediately before administration. true Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by injection. true Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Has basic dose form (attribute) A solid dose form consisting of one or more particulate solids of varying degrees of fineness. true Inferred relationship Some
Powder for conventional release solution for infusion (dose form) Is a Powder for conventional release solution for infusion and/or injection (dose form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial Has manufactured dose form True Powder for conventional release solution for infusion (dose form) Inferred relationship Some
Coagulation factor IX 500 unit powder for solution for infusion vial Has manufactured dose form True Powder for conventional release solution for infusion (dose form) Inferred relationship Some
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form False Powder for conventional release solution for infusion (dose form) Inferred relationship Some
Product containing precisely remimazolam (as remimazolam besylate) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion (dose form) Inferred relationship Some
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form True Powder for conventional release solution for infusion (dose form) Inferred relationship Some

Start Page 2 of 2

This concept is not in any reference sets

Back to Start